Lisa Callagher
Christopher Cullis



That COVID-19 has changed multiple facets of our working and social lives is a claim that few would challenge. COVID-19 also changed the focus of the business of biotechnology and how business is done. New collaborations rapidly formed and cooperated openly, collegially, and virtually in ways rarely seen in a field where intellectual property rights loom large.